Selection of individuals who may benefit from pancreatic cancer surveillance.
作者信息
Bruno Marco J
机构信息
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center, Rotterdam, the Netherlands.
出版信息
United European Gastroenterol J. 2024 Dec;12(10):1342-1343. doi: 10.1002/ueg2.12660. Epub 2024 Nov 1.
Abstract
摘要
相似文献
1
Selection of individuals who may benefit from pancreatic cancer surveillance.选择可能从胰腺癌监测中获益的个体。
United European Gastroenterol J. 2024 Dec;12(10):1342-1343. doi: 10.1002/ueg2.12660. Epub 2024 Nov 1.
2
Pancreatic Cancer Surveillance: Who, When, and How.胰腺癌监测：对象、时机与方式。
Curr Treat Options Gastroenterol. 2019 Dec;17(4):681-691. doi: 10.1007/s11938-019-00247-0.
3
Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.参与年度胰腺癌监测的个体中与癌症担忧相关的因素。
Fam Cancer. 2017 Jan;16(1):143-151. doi: 10.1007/s10689-016-9930-4.
4
Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance.胰腺癌监测中高危人群强化监测和手术的患者报告负担。
Fam Cancer. 2020 Jul;19(3):247-258. doi: 10.1007/s10689-020-00171-8.
5
Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant.携带种系CDKN2A致病变异的家庭中的心理困扰与生活质量
Mol Genet Genomic Med. 2025 Feb;13(2):e70045. doi: 10.1002/mgg3.70045.
6
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.BRCA1/2 种系致病性变异携带者中胰腺癌监测的获益。
Cancer. 2024 Jan;130(2):256-266. doi: 10.1002/cncr.35052. Epub 2023 Oct 20.
7
Hereditary pancreatic cancer.遗传性胰腺癌。
Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101783. doi: 10.1016/j.bpg.2021.101783. Epub 2022 Jan 3.
8
Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals.高危个体胰腺癌监测的当前方法
J Gastrointest Cancer. 2025 Feb 11;56(1):61. doi: 10.1007/s12029-025-01184-1.
9
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.遗传性胰腺癌监测的成本效益综述。
Fam Cancer. 2024 Aug;23(3):351-360. doi: 10.1007/s10689-024-00392-1. Epub 2024 May 25.
10
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.高危人群胰腺癌监测的获益：来自三个欧洲专家中心的长期前瞻性随访研究结果。
J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.
本文引用的文献
1
Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families.胰腺癌筛查对于存在易感种系基因突变的个体是有效的，但对于种系基因突变阴性的家族性胰腺癌家族则无效。
United European Gastroenterol J. 2024 Nov;12(9):1211-1221. doi: 10.1002/ueg2.12631. Epub 2024 Jul 19.
2
Burden of pancreatic cancer in older adults globally, regionally, and in 204 countries: 1990-2019 and projections to 2030.全球、地区和 204 个国家 1990 年至 2019 年及 2030 年预测老年人胰腺癌负担。
J Gastrointest Surg. 2024 Feb;28(2):121-131. doi: 10.1016/j.gassur.2023.12.001. Epub 2024 Feb 5.
3
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.可切除和交界可切除胰腺癌的新辅助治疗或 upfront 手术：随机对照试验的荟萃分析。
Eur J Cancer. 2022 Jan;160:140-149. doi: 10.1016/j.ejca.2021.10.023. Epub 2021 Nov 24.
4
Long-term yield of pancreatic cancer surveillance in high-risk individuals.高危人群的胰腺癌监测的长期获益。
Gut. 2022 Jun;71(6):1152-1160. doi: 10.1136/gutjnl-2020-323611. Epub 2021 Apr 5.
5
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.在控制了确诊偏倚和队列效应后，BRCA1/BRCA2家族中的遗传早现现象。
Cancer. 2016 Jun 15;122(12):1913-20. doi: 10.1002/cncr.29972. Epub 2016 Mar 15.
Zotero 插件